Nonalcoholic steatosis hepatitis (NASH) is a major cause of cirrhosis and liver cancer. The disease is most common in obese people, type 2 diabetic patients, hypertension, and hyperlipidemia. Professor Danny Mannor of the Case Western Reserve University School of Medicine and his team studied a group of experimental mice with NASH.
A number of recent studies have found that vitamin E can alleviate some of the symptoms of NASH. This indicates a certain correlation between vitamin E levels and liver disease. To confirm this hypothesis, Professor Manol and colleagues conducted experiments on experimental mice lacking vitamin E. It was found that when the rats were deficient in vitamin E, the symptoms of other liver damage such as fat accumulation increased significantly. When these rats were supplemented with vitamin E, their NASH symptoms improved significantly.
Professor Mannor said that this result confirms that vitamin E levels do affect the symptoms of liver disease, and the antioxidant properties of vitamin E play a key role. The new findings are undoubtedly a boon for patients with fatty liver.